Insect Bite Hypersensitivity in Horses: Causes, Diagnosis, Scoring and New Therapies.
Authors: Cox Abbey, Stewart Allison J
Journal: Animals : an open access journal from MDPI
Summary
Insect bite hypersensitivity (IBH, commonly known as sweet itch or Queensland itch) represents the most prevalent pruritic condition affecting horses worldwide, with prevalence rates reaching 60% in some regions and predominantly triggered by hypersensitivity to Culicoides midge saliva. Cox and Allison's 2023 review synthesises current understanding of aetiologic agents, pathophysiological mechanisms, and diagnostic approaches, whilst critically evaluating management strategies ranging from established prevention methods (stabling, protective rugs, repellents) and symptomatic treatments (systemic and topical corticosteroids, antihistamines) to emerging immunological interventions including vaccines and desensitisation protocols. Key findings highlight that whilst IBH remains incurable and demands lifelong, resource-intensive management, newly validated severity grading systems now enable standardised documentation of disease progression and robust comparison of therapeutic efficacy across clinical trials—a significant advancement given the substantial animal welfare implications of secondary self-trauma and chronic pruritus. For equine practitioners, this synthesis underscores the importance of implementing individualised, multi-modal management approaches tailored to each horse's environmental exposure and response profile, whilst remaining alert to promising immunotherapeutic developments that may eventually reduce treatment burden and improve long-term quality of life for affected animals.
Read the full abstract on PubMed
Practical Takeaways
- •IBH management requires lifelong commitment combining preventive measures (stabling, fans, rugs, repellents) with symptomatic treatment (corticosteroids, antihistamines, healing creams); set client expectations accordingly
- •New grading systems are being validated to document disease severity, allowing better comparison of treatment efficacy—familiarize yourself with emerging assessment tools
- •Emerging immune-based therapies (vaccines, desensitization) may offer improved long-term control; stay updated on clinical trial results as new options become available
Key Findings
- •IBH is the most common pruritic disease of horses with prevalence reported as high as 60% in some parts of the world
- •IBH is most often caused by hypersensitivity to Culicoides spp. biting midge saliva, though other insect species can also trigger the condition
- •Currently no cure exists for IBH; management is lifelong, time-consuming and costly
- •New immune-mediated therapeutics including vaccines and desensitisation procedures show promise for controlling hypersensitivity reactions